Skip to main content
. 2016 Nov 9;7(48):79995–80007. doi: 10.18632/oncotarget.13237

Figure 4. The cell proliferation rates of CL1-0 and CL1-5 cells without p-Akt after MMC treatment.

Figure 4

A. The activity of p-Akt was measured by immunoblot analyses in MK-2206-treated or MK-2206-untreated CL1-0 and CL1-5 cells with or without MMC treatment. Loading control: actin. B. The cell proliferation rates of CL1-0 and CL1-5 cells that were untreated, treated with MK-2206, treated with MMC, or treated with a combination of MK-2206 and MMC. *P < 0.05, n = 3. C. Colony formation of CL1-0 and CL1-5 cells that were untreated, treated with MK-2206, treated with MMC or with a combination of MK-2206 and MMC. **P < 0.01, n = 4. All values are represented as mean +/− SEM.